# FDA Warning Letter: Jagsonpal Pharmaceuticals Limited
> 2025-02-18 · Center for Drug Evaluation and Research (CDER) · `cc8ce3967153f759`
## Letter
- **Company:** Jagsonpal Pharmaceuticals Limited
- **Posted Date:** 2025-02-18
- **Letter Issue Date:** 2025-02-05
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceutical/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*